Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: A report from The International DLBCL Rituximab-CHOP Consortium Program Meeting Abstract
| Authors: | Shen, Q.; Xu-Monette, Z. Y.; Manyam, G. C.; Visco, C.; Tzankov, A.; Cao, X.; Deng, L. J.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y. L.; Bhagat, G.; Richards, K. L.; Hsi, E. D.; Choi, W. W. L.; van Krieken, J. H.; Huh, J.; Ponzoni, M.; Ferreri, A. J. M.; Farnen, J. P.; Moller, M. B.; Winter, J. N.; Piris, M. A.; Medeiros, L. J.; Young, K. H. |
| Abstract Title: | Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: A report from The International DLBCL Rituximab-CHOP Consortium Program |
| Meeting Title: | 2nd Annual Meeting of the Society of Hematalogic Oncology (SOHO 2014) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 15 |
| Issue: | SUppl. 1 |
| Meeting Dates: | 2014 Sep 17-20 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-06-01 |
| Start Page: | S220 |
| End Page: | S221 |
| Language: | English |
| ACCESSION: | WOS:000370676300117 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.clml.2015.04.096 |
| Notes: | Meeting Abstract: 511 -- Source: Wos |
